APPLICATION
NDA013319
TYPE
NDA
ORIGINAL APPROVAL
1996-04-26
LATEST ACTION
1996-04-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ANGIO-CONRAYDiscontinued
IOTHALAMATE SODIUM 80% · INJECTABLE · INJECTION
Approval history
1996-04-26Type 2 - New Active Ingredient · Original · standardAP
1996-04-26Labeling · Supplement 24AP
1996-04-26Labeling · Supplement 22AP
1996-04-26Labeling · Supplement 19AP
1996-04-26Labeling · Supplement 25AP
1989-06-28Labeling · Supplement 33AP
1985-04-16Labeling · Supplement 30AP
1982-10-19Labeling · Supplement 27AP
1976-05-06Labeling · Supplement 21AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.